We identified 22 differentially expressed miRs in HER2-overexpressing (HER2+) tumours, 31 in Basal-like tumours and 33 in Luminal tumours (Supporting Information Tables S2 and S3A–S3C). Here, ERBB2 is linked to neoplasm.